Abstract

Oncocytic (Hurthle cell) adenoma is A Rare, Benign tumor of the thyroid gland. A 66-yearold woman presented with midline painless neck swelling over the past 3 months. The swelling moves up and down with her swallowing. On examination the swelling measured about 3x3x2.4 cm in size, in the right lobe of the thyroid gland. There was no symptoms of palpitation, hoarseness, or any pressure related signs. There was no family history of thyroid cancer. The ultrasonography showed right thyroid well circumscribed, heterogenous nodular mass lesion measuring 3.0x3.6 cm. Fine niddle aspiration cytology showed moderately cellular smears composed predominantly of Hürthle cells with abundant fine granular cytoplasm. Cellular atypia was noted. On cytology reported as suspicious for a follicular neoplasm with Hürthle cell type. Our patient underwent simple lobectomy. On histopathological findings reported as Oncocytic cell adenoma thyroid. Patient showed a good postoperative prognosis. This article presents a case of Oncocytic/Hurthle cell adenoma of the thyroid gland with a review of literature.

• 1.   Chan Kwon Jung, Andrey Bychkov, KennichiKakudo. Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approace. EndocrinolMetab. 2022;37(5):703-718.
• 2.   RV Lloyd, RY Osamura, GRJ Klöppel, eds. World Health Organization Classification of Tumours of Endocrine Organs. 4th ed. IARC Press; 2017.
• 3.   Stojadinovic A, Hoos A, Ghossein RA, et al. Hurthle cell carcinoma: a 60-year experience. Ann Surg Oncol. 2002;9:197–203.
• 4.   Maximo V, Botelho T, Capela J, Soares P, Lima J, Taveira A, et al. Somatic and Germline Mutation in GRIM-19, a Dual Function Gene Involved in Mitochondrial Metabolism and Cell Death, is Linked to Mitochondrion-Rich (Hurthle Cell) Tumours of the Thyroid. Br J Cancer, 2005, 92(10):1892–8.
• 5.   Askanazy M. PatologischAnatomischeBeitrage Zur KenntissDes Morbus Basedowii, Insbesondere Uber Die Dabei AuftretendeMuskelerkrankung. Deutsch Arch Klin Med. 1898, 61:118–86.
• 6.   Baloch ZW, LiVolsi VA, Asa SL, et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. DiagnCytopathol. 2008;36:425–437.
• 7.   Asa SL. My Approach to Oncocytic Tumours of the Thyroid. J Clin Pathol. 2004, 57(3):225–32.
• 8.   Jagtap SV, Patil D, Chetan, Gupta SO. Papillary carcinoma thyroid presented with extensive local lymph nodal metastasis. IP Arch Cytol Histopathol Res 2018;3:113-5.
• 9.   Wasvary H, Czako P, Poulik J, Lucas R. Unilateral lobectomy for Hurthle cell adenoma. Am Surg. 1998 ;64(8):729-32.
• 10.   Saull SC, Kimmelman CP. Hürthle cell tumors of the thyroid gland. Otolaryngol Head Neck Surg. 1985 ;93(1):58-62.
• 11.   Bronner MP, VA L. Oxyphilic (Askanazy/ Hurthle cell) tumors of the thyroid: microscopic features predict biologic behavior. SurgPathol. 1988;1:137-50.
• 12.   Har-El G, Hadar T, Segal K, Levy R, Sidi J. Hurthle cell carcinoma of the thyroid gland. A tumor of moderate malignancy. Cancer. 1986, 15;57(8):1613-7.
• 13.   Ghossein RA, Hiltzik DH, Carlson DL, Patel S, Shaha A, Shah JP, Tuttle RM, Singh B. Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases. Cancer. 2006,15;106(8):1669-76.

Data Sharing Statement

Funding